We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




An Innovative Inserter Simplifies Intraocular Lens Placement

By HospiMedica International staff writers
Posted on 22 Jun 2009
A new single use insertion device for intraocular lenses (IOLs) has been designed to combine both ease of use with controlled delivery. More...


The Epiphany injector system is intended for insertion of designated new technology intraocular lens (NTIOL) lenses. The single use inserter offers flexibility, enabling the use of either the twist or push insertion techniques. The system provides for planar delivery of the lens into the eye via controlled insertion through a 2.8 mm incision, and ensures a sterile pathway into the eye, assisting in the correct placement of the lens leading haptic. The Epiphany injector system is a manufactured by STAAR Surgical (Nidau, Switzerland), and is intended for use with the company's Affinity collagen copolymer lens (Collamer) three-piece NTIOL and the Elastimide 3-piece or single piece silicone NTIOL.

"The Epiphany Injector System is an important extension of STAAR Japan's expertise in the area of preloaded delivery systems for foldable IOLs which have been very successful in the Japanese market,” said Barry G. Caldwell, President and CEO of STAAR Surgical. "This product will enhance the ability of surgeons to accurately deliver the Collamer Three-Piece NTIOL into the eye.”

An NTIOL is defined as an IOL that has been determined--for medical reimbursement purposes--by the U.S. Food and Drug Administration (FDA) to posses specific clinical advantages and superiority over existing IOLs, with regard to reduced risk of intraoperative or postoperative complication or trauma, accelerated postoperative recovery, reduced induced astigmatism, improved postoperative visual acuity, more stable postoperative vision, or other comparable clinical advantages.

Related Links:
STAAR Surgical


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Medical Examination & Procedure Light
Vega 80
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.